TABLE 1

Cervical cancer screening among average-risk patients

Organization	Recommended screening test and frequency
2018 US Preventive Services Task Force¹³	Age < 21 years No screening	Age 21–29 years Cervical cytology (Pap test) every 3 years	Age 30–65 years Choose between Cervical cytology (Pap test) every 3 years, or Primary HPV testing every 5 years, or Cotesting every 5 years

2020 American Cancer Society¹²	Age 25–65 years Primary HPV testing every 5 years preferred
2020 American Cancer Society¹²	Acceptable alternatives (given access to primary HPV testing may be limited): Cotesting every 5 years, or Cervical cytology (Pap test) every 3 years